Final Programme 2019

26 SCIENTIFIC PROGRAMME Friday, 26 April 2019 HT-10 Hot Topic Symposium 16:00–17:30 Room 5 A Who are the ADHD patients who respond to neuro- therapies? Chairs: A. Fallgatter, Germany K. Rubia, United Kingdom HT-10-001 Evidence-based EEG-neurofeedback: How, when and for whom D. Brandeis, Switzerland HT-10-002 Results from the double-blind two-site randomised International Collaborative ADHD Neurofeedback (ICAN) study M. Arns, The Netherlands HT-10-003 Optimization of NIRS-based neurofeedback in ADHD by virtual reality A. Fallgatter, Germany HT-10-004 Effectiveness of fMRI-neurofeedback and non-invasive brain stimulation K. Rubia, United Kingdom HT-11 Hot Topic Symposium 16:00–17:30 Auditorium IV Hot topic in research: What we need in the field to better understand ADHD? The new big data studies or small studies with well-defined phenotype? Chairs: S. Faraone, USA HT-11-001 We need big data studies rather than small studies with deep phenotyping B. Franke, The Netherlands HT-11-002 We need small studies rather than big data studies with deep phenotyping J. A. Sergeant, The Netherlands HT-12 Hot Topic Symposium 16:00–17:30 Auditorium II New concepts and approaches to study ADHD Chairs: M. Romanos, Germany A. Thapar, United Kingdom HT-12-001 ESCAlife: Evidence-based, stepped care of ADHD along the life-span M. Romanos, Germany HT-12-002 Population neuroscience of the adolescent brain: Outlining possible strategies for stratified preventive strategies in ADHD T. Paus, Canada HT-12-003 The NIH ECHO initiative for examination of environmental factors contributing to neuropsychiatric disorders including ADHD J. Schweitzer, USA HT-12-004 Is there yet a role for longitudinal epide- miological studies and natural experiments to inform our understanding of ADHD? A. Thapar, United Kingdom HT-13 Hot Topic Symposium 16:00–17:30 Room 5 C Pre-, peri- and postnatal risk factors in the development of ADHD Chairs: M. E. Narad, USA I. C. K. Wong, United Kingdom HT-13-001 Prenatal antidepressant use and risk of ADHD in offspring: Population based co- hort study I. C. K. Wong, United Kingdom HT-13-002 Pregnancy-induced hypertension and other early life influences in the development of ADHD: Results from the IDEFICS study I. Pigeot, Germany HT-13-003 Is intrauterine exposure to acetaminophen associated with emotional and hyperactiv- ity problems during childhood? L. Tovo-Rodrigues, Brazil HT-13-004 Secondary ADHD in children and adolescent 5 to 10 years after traumatic brain injury M. E. Narad, USA HT-14 Hot Topic Symposium 16:00–17:30 Auditorium I The controversial use, new use, and misuse of psycho- stimulants Chairs: B. Sahakian, United Kingdom M. Stein, USA HT-14-001 Ethical issues in the use of psychostimulants M. Stein, USA HT-14-002 Cognitive enhancers in ADHD and healthy people B. Sahakian, United Kingdom

RkJQdWJsaXNoZXIy Mzg2Mjgy